Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

ZIOP

ZIOPHARM Oncology (ZIOP)

ZIOPHARM Oncology Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ZIOP
FechaHoraFuenteTítuloSímboloCompañía
12/06/202315:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
08/06/202316:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZIOPZIOPHARM Oncology Inc
10/05/202306:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ZIOPZIOPHARM Oncology Inc
25/04/202316:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ZIOPZIOPHARM Oncology Inc
19/04/202315:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ZIOPZIOPHARM Oncology Inc
14/04/202316:06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ZIOPZIOPHARM Oncology Inc
07/03/202306:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
14/02/202312:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ZIOPZIOPHARM Oncology Inc
30/11/202216:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ZIOPZIOPHARM Oncology Inc
08/09/202205:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ZIOPZIOPHARM Oncology Inc
31/08/202215:44Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:ZIOPZIOPHARM Oncology Inc
12/08/202216:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ZIOPZIOPHARM Oncology Inc
08/07/202215:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ZIOPZIOPHARM Oncology Inc
26/01/202206:00GlobeNewswire Inc.Ziopharm Oncology Highlights Operational Progress & Rebrands to Alaunos TherapeuticsNASDAQ:ZIOPZIOPHARM Oncology Inc
22/11/202103:05TipRanksH.C. Wainwright Reiterates a Hold Rating on Ziopharm Oncology (ZIOP)NASDAQ:ZIOPZIOPHARM Oncology Inc
09/11/202107:05GlobeNewswire Inc.Ziopharm Oncology Presents Preclinical Data Supporting TCR-T Library Approach at the Society for Immunotherapy of Cancer 2021 Annual MeetingNASDAQ:ZIOPZIOPHARM Oncology Inc
08/11/202115:10GlobeNewswire Inc.Ziopharm Oncology Reports Third Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:ZIOPZIOPHARM Oncology Inc
01/11/202115:30GlobeNewswire Inc.Ziopharm Oncology to Report Third Quarter Financial Results on November 8, 2021NASDAQ:ZIOPZIOPHARM Oncology Inc
14/10/202105:49TipRanksUnderstanding Changes in Ziopharm Oncology’s Risk FactorsNASDAQ:ZIOPZIOPHARM Oncology Inc
01/09/202115:05GlobeNewswire Inc.Ziopharm Oncology to Participate in September Investor ConferencesNASDAQ:ZIOPZIOPHARM Oncology Inc
30/08/202107:30GlobeNewswire Inc.Ziopharm Oncology Appoints Kevin S. Boyle, Sr., as Chief Executive Officer and Announces other Executive PromotionsNASDAQ:ZIOPZIOPHARM Oncology Inc
09/08/202116:08Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ZIOPZIOPHARM Oncology Inc
09/08/202115:05GlobeNewswire Inc.Ziopharm Oncology Provides Second Quarter 2021 Corporate UpdatesNASDAQ:ZIOPZIOPHARM Oncology Inc
26/07/202115:30GlobeNewswire Inc.Ziopharm Oncology to Report Second Quarter Financial Results on August 9, 2021NASDAQ:ZIOPZIOPHARM Oncology Inc
24/05/202115:05GlobeNewswire Inc.Ziopharm Oncology to Participate in Upcoming ConferencesNASDAQ:ZIOPZIOPHARM Oncology Inc
19/05/202115:05GlobeNewswire Inc.Ziopharm Oncology Reinforces Clear and Bold Vision for Delivering Value at Annual Shareholders MeetingNASDAQ:ZIOPZIOPHARM Oncology Inc
06/05/202115:02GlobeNewswire Inc.Ziopharm Oncology Reports First Quarter 2021 Financial Results and Provides Corporate UpdatesNASDAQ:ZIOPZIOPHARM Oncology Inc
04/05/202107:00GlobeNewswire Inc.Ziopharm Oncology Scientific Advisor Laurence Cooper, MD, PhD, to Present at University of Pennsylvania Cellicon Valley ’21...NASDAQ:ZIOPZIOPHARM Oncology Inc
29/04/202108:00GlobeNewswire Inc.Ziopharm Oncology to Report First Quarter Financial Results on May 6, 2021NASDAQ:ZIOPZIOPHARM Oncology Inc
28/04/202115:05GlobeNewswire Inc.Ziopharm Oncology Scientific Advisor Laurence J. N. Cooper, PhD, MD, Presented Today at Aldevron’s Virtual Breakthrough Spe...NASDAQ:ZIOPZIOPHARM Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:ZIOP